Testosterone therapy may help older men live longer

The first of these was men who the treatment restored to normal testosterone levels, those who underwent treatment but did not manage to return to such levels, and men who had no treatment at all. The study was published online August 6, 2015, in the European Heart Journal.

It has been a back and forth issue, but it seems a new study found that testosterone therapy protects men from heart issues and nudging the scale toward its benefits. Unlike other studies that have evaluated TRT and cardiovascular events, participants were excluded if they had a documented myocardial infarction (MI) or stroke prior to the assessment of their TT levels.

For the study, the subjects were split into three distinct groups.

The new VA study is likely to draw attention because of its large size and relatively long follow-up period. It’s well known among the medical community that testosterone levels progressively lower as men advance through life. Testosterone isn’t prescribed with the goal of improving heart health, but that is a consideration in many cases.

Earlier this year, the Food and Drug Administration ordered testosterone replacement therapies to carry warnings on their labels of an increased risk of heart attack and stroke.

Dr. Rajat Baru, is a cardiologist with the Kansas City Veterans Affairs Medical Center.

The sharpest contrast emerged between those who were treated and attained normal levels and those whose low testosterone levels were untreated. MD Aaron Michelfelder, family physician from Loyola University’s Health System, believes that not all older men should be treated with hormone therapy. The investigators used propensity score matching to account for covariates, such as age, body mass index, diabetes, hypertension, coronary artery disease, and use of aspirin or statins. 6 to six. 2 years after remedy. Lastly, they were 36 percent less likely to have a stroke. Group 1 received TRT and subsequently saw normalization of their testosterone levels (confirmed by repeat testing). Other groups say no such benefit.

Dr. Barua and his colleagues go on to say that they do not necessarily understand this inherent relationship, but that the research is promising. “The mechanisms for these results stay speculative”, they wrote.

While the new study results do seem to advocate for testosterone replacement therapy, Barua stresses the need for “appropriate screening, selection, dosing, and follow-up of patients to maximize the benefit of testosterone therapy”. While his background is mainly rooted in sports writing, he has also written and edited guides, ebooks, short stories and screenplays. He gave a statement saying that only men who have low testosterone levels and show symptoms should be considered for testosterone replacement therapy. Examples of these conditions include failure of the testicles to produce testosterone because of reasons such as genetic problems or chemotherapy….